MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36180) - Retirement - Effective August 17, 2025

Date Posted: August 21, 2025

This Local Coverage Determination (LCD) has been retired under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Medicare Coverage Database (MCD) Number: L36180

Effective Date: August 17, 2025

Rationale: L36180 MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease and A57421 Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease will be retired on 8/17/2025 because the information in the LCD and article have been incorporated within the MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms L39923 LCD and related article.

Visit the Retired LCDs webpage to access the retired LCDs.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )